| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Waverley Pharma Inc (V: WAVE)
WAVE Technical Analysis
5
| As on 21st Nov 2024 WAVE STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
WAVESTOCK Price
| Open | 0.02 | Change | Price | % |
| High | 0.02 | 1 Day | 0.01 | 100.00 |
| Low | 0.02 | 1 Week | 0.00 | 0.00 |
| Close | 0.02 | 1 Month | 0.00 | 0.00 |
| Volume | 1000 | 1 Year | -0.02 | -50.00 |
| 52 Week High 0.05 | 52 Week Low 0.01 | ||||
V Canada Most Active Stocks
| NU | 14.06 | -7.44% |
| TVI | 0.01 | 0.00% |
| DM | 0.00 | % |
| DMGI | 0.44 | 7.32% |
| FUU | 0.24 | 0.00% |
| SC-H | 0.08 | 100.00% |
| THRM | 0.02 | 0.00% |
| LUCK | 70.00 | 2.94% |
| MAI | 0.29 | -3.33% |
| MGM | 0.06 | 20.00% |
V Canada Top Gainers Stocks
V Canada Top Losers Stocks
| WAVE Daily Charts |
WAVE Intraday Charts |
Whats New @ Bazaartrend |
WAVE Free Analysis |
|
|
WAVE Important Levels Intraday
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
WAVE Forecast November 2024
| 4th UP Forecast | 0.06 |
| 3rd UP Forecast | 0.05 |
| 2nd UP Forecast | 0.04 |
| 1st UP Forecast | 0.03 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.02 |
WAVE Weekly Forecast
| 4th UP Forecast | 0.06 |
| 3rd UP Forecast | 0.05 |
| 2nd UP Forecast | 0.04 |
| 1st UP Forecast | 0.03 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | 0.00 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.02 |
WAVE Forecast2024
| 4th UP Forecast | 0.1 |
| 3rd UP Forecast | 0.07 |
| 2nd UP Forecast | 0.06 |
| 1st UP Forecast | 0.04 |
| 1st DOWN Forecast | -0 |
| 2nd DOWN Forecast | -0.02 |
| 3rd DOWN Forecast | -0.03 |
| 4th DOWN Forecast | -0.06 |
Waverley Pharma Inc ( V Canada Symbol : WAVE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
WAVE Business Profile
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes cancer therapeutics in the United Kingdom, European Union, and North America. It focuses on the generic oncology injectable products. The company sells generic oncology products comprising capecitabine, temozolomide, and erlotinib. Its products under development include injectable generic chemotherapy drugs, such as WAV-101 for the treatment of non-small cell lung cancer and pleural mesothelioma; and WAV-102 to treat multiple myeloma and mantle cell lymphoma. The company has a collaboration with the University of Manitoba for the development of a synthetic library of chloroquine analogs to treat COVID-19. Waverley Pharma Inc. is headquartered in Winnipeg, Canada. Address: 4-1250 Waverley Street, Winnipeg, MB, Canada, R3T 6C6
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service